Tags : In-Vivo Study

Xbrane Biopharma Reports Results of Xlucane Compared to Lucentis from

Shots: The in-vivo study was evaluated on group of rabbits administering bilateral intravitreal injection of Xlucane (ranibisumab, Lucentis biosimilar) vs Lucentis divided in two equal groups, testing its PK and tolerability in both the serum and the eyeglass body The results show Xlucane is well tolerated with no ocular inflammation in eyes, with equivalent PK […]Read More